Global Diabetes Medicines Production, Demand and Key Producers, 2022-2028
This report studies the global Diabetes Medicines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Diabetes Medicines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diabetes Medicines that contribute to its increasing demand across many markets.
The global Diabetes Medicines market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Diabetes Medicines total production and demand, 2017-2028, (K Units)
Global Diabetes Medicines total production value, 2017-2028, (USD Million)
Global Diabetes Medicines production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Diabetes Medicines consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Diabetes Medicines domestic production, consumption, key domestic manufacturers and share
Global Diabetes Medicines production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Diabetes Medicines production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Diabetes Medicines production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Diabetes Medicines market based on the following parameters – headquarters, production locations, products portfolio, Diabetes Medicines revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diabetes Medicines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Diabetes Medicines Market, By Region:
1. How big is the global Diabetes Medicines market?
2. What is the demand of the global Diabetes Medicines market?
3. What is the year over year growth of the global Diabetes Medicines market?
4. What is the production and production value of the global Diabetes Medicines market?
5. Who are the key producers in the global Diabetes Medicines market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Diabetes Medicines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diabetes Medicines that contribute to its increasing demand across many markets.
The global Diabetes Medicines market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Diabetes Medicines total production and demand, 2017-2028, (K Units)
Global Diabetes Medicines total production value, 2017-2028, (USD Million)
Global Diabetes Medicines production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Diabetes Medicines consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Diabetes Medicines domestic production, consumption, key domestic manufacturers and share
Global Diabetes Medicines production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Diabetes Medicines production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Diabetes Medicines production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Diabetes Medicines market based on the following parameters – headquarters, production locations, products portfolio, Diabetes Medicines revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diabetes Medicines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Diabetes Medicines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Insulin
- DPP-4
- GLP-1
- SGLT-2
- Type 1 Diabetes
- Type 2 Diabetes
- Sanofi
- AstraZeneca
- Bayer
- Biocon
- Boehringer Ingelheim
- Dongbao Pharmaceutical
- Eli Lilly
- Ganlee
- Ginwa
- Guangzhou Baiyun Mountain
- Hisun Pharmacy
- Hua Dong
- Huadong Medicine
- Jumpcan Pharmacy
- KELUN
- Merck & Co.
- MSD
- North China Pharmaceutical Group Corporation
- Novartis
- Novo Nordisk
- Sanofi
- SHIJIAZHUANG YILING PHARMACEUTICAL
- Takeda
- Taloph
- Tianan Pharmaceutical
- Tonghua DongBao
- Wanbang Biopharmaceuticals
1. How big is the global Diabetes Medicines market?
2. What is the demand of the global Diabetes Medicines market?
3. What is the year over year growth of the global Diabetes Medicines market?
4. What is the production and production value of the global Diabetes Medicines market?
5. Who are the key producers in the global Diabetes Medicines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Diabetes Medicines Introduction
1.2 World Diabetes Medicines Supply & Forecast
1.2.1 World Diabetes Medicines Production Value (2017 & 2021 & 2028)
1.2.2 World Diabetes Medicines Production (2017-2028)
1.2.3 World Diabetes Medicines Pricing Trends (2017-2028)
1.3 World Diabetes Medicines Production by Region
1.3.1 World Diabetes Medicines Production Value by Region (2017-2028)
1.3.2 World Diabetes Medicines Production by Region (2017-2028)
1.3.3 World Diabetes Medicines Average Price by Region (2017-2028)
1.3.4 North America Diabetes Medicines Production (2017-2028)
1.3.5 Europe Diabetes Medicines Production (2017-2028)
1.3.6 China Diabetes Medicines Production (2017-2028)
1.3.7 Japan Diabetes Medicines Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Diabetes Medicines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Diabetes Medicines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Diabetes Medicines Demand (2017-2028)
2.2 World Diabetes Medicines Consumption by Region
2.2.1 World Diabetes Medicines Consumption by Region (2017-2022)
2.2.2 World Diabetes Medicines Consumption Forecast by Region (2023-2028)
2.3 United States Diabetes Medicines Consumption (2017-2028)
2.4 China Diabetes Medicines Consumption (2017-2028)
2.5 Europe Diabetes Medicines Consumption (2017-2028)
2.6 Japan Diabetes Medicines Consumption (2017-2028)
2.7 South Korea Diabetes Medicines Consumption (2017-2028)
2.8 ASEAN Diabetes Medicines Consumption (2017-2028)
2.9 India Diabetes Medicines Consumption (2017-2028)
3 WORLD DIABETES MEDICINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Diabetes Medicines Production Value by Manufacturer (2017-2022)
3.2 World Diabetes Medicines Production by Manufacturer (2017-2022)
3.3 World Diabetes Medicines Average Price by Manufacturer (2017-2022)
3.4 Diabetes Medicines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Diabetes Medicines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Diabetes Medicines in 2021
3.5.3 Global Concentration Ratios (CR8) for Diabetes Medicines in 2021
3.6 Diabetes Medicines Market: Overall Company Footprint Analysis
3.6.1 Diabetes Medicines Market: Region Footprint
3.6.2 Diabetes Medicines Market: Company Product Type Footprint
3.6.3 Diabetes Medicines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Diabetes Medicines Production Value Comparison
4.1.1 United States VS China: Diabetes Medicines Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Diabetes Medicines Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Diabetes Medicines Production Comparison
4.2.1 United States VS China: Diabetes Medicines Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Diabetes Medicines Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Diabetes Medicines Consumption Comparison
4.3.1 United States VS China: Diabetes Medicines Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Diabetes Medicines Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Diabetes Medicines Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Diabetes Medicines in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Diabetes Medicines Production by Domestic Manufacturer, (2017-2022)
4.5 China Diabetes Medicines Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Diabetes Medicines in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Diabetes Medicines Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Diabetes Medicines Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Diabetes Medicines in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Diabetes Medicines Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Diabetes Medicines Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Insulin
5.2.2 DPP-4
5.2.3 GLP-1
5.2.4 SGLT-2
5.3 Market Segment by Type
5.3.1 World Diabetes Medicines Production by Type (2017-2028)
5.3.2 World Diabetes Medicines Production Value by Type (2017-2028)
5.3.3 World Diabetes Medicines Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Diabetes Medicines Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Type 1 Diabetes
6.2.2 Type 2 Diabetes
6.3 Market Segment by Application
6.3.1 World Diabetes Medicines Production by Application (2017-2028)
6.3.2 World Diabetes Medicines Production Value by Application (2017-2028)
6.3.3 World Diabetes Medicines Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Diabetes Medicines Product and Services
7.1.4 Sanofi Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Diabetes Medicines Product and Services
7.2.4 AstraZeneca Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Diabetes Medicines Product and Services
7.3.4 Bayer Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Biocon
7.4.1 Biocon Details
7.4.2 Biocon Major Business
7.4.3 Biocon Diabetes Medicines Product and Services
7.4.4 Biocon Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Biocon Recent Developments/Updates
7.4.6 Biocon Competitive Strengths & Weaknesses
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Details
7.5.2 Boehringer Ingelheim Major Business
7.5.3 Boehringer Ingelheim Diabetes Medicines Product and Services
7.5.4 Boehringer Ingelheim Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Boehringer Ingelheim Recent Developments/Updates
7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.6 Dongbao Pharmaceutical
7.6.1 Dongbao Pharmaceutical Details
7.6.2 Dongbao Pharmaceutical Major Business
7.6.3 Dongbao Pharmaceutical Diabetes Medicines Product and Services
7.6.4 Dongbao Pharmaceutical Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Dongbao Pharmaceutical Recent Developments/Updates
7.6.6 Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.7 Eli Lilly
7.7.1 Eli Lilly Details
7.7.2 Eli Lilly Major Business
7.7.3 Eli Lilly Diabetes Medicines Product and Services
7.7.4 Eli Lilly Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Eli Lilly Recent Developments/Updates
7.7.6 Eli Lilly Competitive Strengths & Weaknesses
7.8 Ganlee
7.8.1 Ganlee Details
7.8.2 Ganlee Major Business
7.8.3 Ganlee Diabetes Medicines Product and Services
7.8.4 Ganlee Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Ganlee Recent Developments/Updates
7.8.6 Ganlee Competitive Strengths & Weaknesses
7.9 Ginwa
7.9.1 Ginwa Details
7.9.2 Ginwa Major Business
7.9.3 Ginwa Diabetes Medicines Product and Services
7.9.4 Ginwa Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Ginwa Recent Developments/Updates
7.9.6 Ginwa Competitive Strengths & Weaknesses
7.10 Guangzhou Baiyun Mountain
7.10.1 Guangzhou Baiyun Mountain Details
7.10.2 Guangzhou Baiyun Mountain Major Business
7.10.3 Guangzhou Baiyun Mountain Diabetes Medicines Product and Services
7.10.4 Guangzhou Baiyun Mountain Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Guangzhou Baiyun Mountain Recent Developments/Updates
7.10.6 Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
7.11 Hisun Pharmacy
7.11.1 Hisun Pharmacy Details
7.11.2 Hisun Pharmacy Major Business
7.11.3 Hisun Pharmacy Diabetes Medicines Product and Services
7.11.4 Hisun Pharmacy Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Hisun Pharmacy Recent Developments/Updates
7.11.6 Hisun Pharmacy Competitive Strengths & Weaknesses
7.12 Hua Dong
7.12.1 Hua Dong Details
7.12.2 Hua Dong Major Business
7.12.3 Hua Dong Diabetes Medicines Product and Services
7.12.4 Hua Dong Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Hua Dong Recent Developments/Updates
7.12.6 Hua Dong Competitive Strengths & Weaknesses
7.13 Huadong Medicine
7.13.1 Huadong Medicine Details
7.13.2 Huadong Medicine Major Business
7.13.3 Huadong Medicine Diabetes Medicines Product and Services
7.13.4 Huadong Medicine Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Huadong Medicine Recent Developments/Updates
7.13.6 Huadong Medicine Competitive Strengths & Weaknesses
7.14 Jumpcan Pharmacy
7.14.1 Jumpcan Pharmacy Details
7.14.2 Jumpcan Pharmacy Major Business
7.14.3 Jumpcan Pharmacy Diabetes Medicines Product and Services
7.14.4 Jumpcan Pharmacy Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Jumpcan Pharmacy Recent Developments/Updates
7.14.6 Jumpcan Pharmacy Competitive Strengths & Weaknesses
7.15 KELUN
7.15.1 KELUN Details
7.15.2 KELUN Major Business
7.15.3 KELUN Diabetes Medicines Product and Services
7.15.4 KELUN Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 KELUN Recent Developments/Updates
7.15.6 KELUN Competitive Strengths & Weaknesses
7.16 Merck & Co.
7.16.1 Merck & Co. Details
7.16.2 Merck & Co. Major Business
7.16.3 Merck & Co. Diabetes Medicines Product and Services
7.16.4 Merck & Co. Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Merck & Co. Recent Developments/Updates
7.16.6 Merck & Co. Competitive Strengths & Weaknesses
7.17 MSD
7.17.1 MSD Details
7.17.2 MSD Major Business
7.17.3 MSD Diabetes Medicines Product and Services
7.17.4 MSD Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 MSD Recent Developments/Updates
7.17.6 MSD Competitive Strengths & Weaknesses
7.18 North China Pharmaceutical Group Corporation
7.18.1 North China Pharmaceutical Group Corporation Details
7.18.2 North China Pharmaceutical Group Corporation Major Business
7.18.3 North China Pharmaceutical Group Corporation Diabetes Medicines Product and Services
7.18.4 North China Pharmaceutical Group Corporation Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 North China Pharmaceutical Group Corporation Recent Developments/Updates
7.18.6 North China Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
7.19 Novartis
7.19.1 Novartis Details
7.19.2 Novartis Major Business
7.19.3 Novartis Diabetes Medicines Product and Services
7.19.4 Novartis Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Novartis Recent Developments/Updates
7.19.6 Novartis Competitive Strengths & Weaknesses
7.20 Novo Nordisk
7.20.1 Novo Nordisk Details
7.20.2 Novo Nordisk Major Business
7.20.3 Novo Nordisk Diabetes Medicines Product and Services
7.20.4 Novo Nordisk Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Novo Nordisk Recent Developments/Updates
7.20.6 Novo Nordisk Competitive Strengths & Weaknesses
7.21 Sanofi
7.21.1 Sanofi Details
7.21.2 Sanofi Major Business
7.21.3 Sanofi Diabetes Medicines Product and Services
7.21.4 Sanofi Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 Sanofi Recent Developments/Updates
7.21.6 Sanofi Competitive Strengths & Weaknesses
7.22 SHIJIAZHUANG YILING PHARMACEUTICAL
7.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Details
7.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
7.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Product and Services
7.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.22.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Developments/Updates
7.22.6 SHIJIAZHUANG YILING PHARMACEUTICAL Competitive Strengths & Weaknesses
7.23 Takeda
7.23.1 Takeda Details
7.23.2 Takeda Major Business
7.23.3 Takeda Diabetes Medicines Product and Services
7.23.4 Takeda Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.23.5 Takeda Recent Developments/Updates
7.23.6 Takeda Competitive Strengths & Weaknesses
7.24 Taloph
7.24.1 Taloph Details
7.24.2 Taloph Major Business
7.24.3 Taloph Diabetes Medicines Product and Services
7.24.4 Taloph Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.24.5 Taloph Recent Developments/Updates
7.24.6 Taloph Competitive Strengths & Weaknesses
7.25 Tianan Pharmaceutical
7.25.1 Tianan Pharmaceutical Details
7.25.2 Tianan Pharmaceutical Major Business
7.25.3 Tianan Pharmaceutical Diabetes Medicines Product and Services
7.25.4 Tianan Pharmaceutical Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.25.5 Tianan Pharmaceutical Recent Developments/Updates
7.25.6 Tianan Pharmaceutical Competitive Strengths & Weaknesses
7.26 Tonghua DongBao
7.26.1 Tonghua DongBao Details
7.26.2 Tonghua DongBao Major Business
7.26.3 Tonghua DongBao Diabetes Medicines Product and Services
7.26.4 Tonghua DongBao Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.26.5 Tonghua DongBao Recent Developments/Updates
7.26.6 Tonghua DongBao Competitive Strengths & Weaknesses
7.27 Wanbang Biopharmaceuticals
7.27.1 Wanbang Biopharmaceuticals Details
7.27.2 Wanbang Biopharmaceuticals Major Business
7.27.3 Wanbang Biopharmaceuticals Diabetes Medicines Product and Services
7.27.4 Wanbang Biopharmaceuticals Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.27.5 Wanbang Biopharmaceuticals Recent Developments/Updates
7.27.6 Wanbang Biopharmaceuticals Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Diabetes Medicines and Key Manufacturers
8.2 Diabetes Medicines Manufacturing Costs
8.3 Diabetes Medicines Production Process
8.4 Diabetes Medicines Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Diabetes Medicines Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Diabetes Medicines Typical Distributors
9.3 Diabetes Medicines Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Diabetes Medicines Introduction
1.2 World Diabetes Medicines Supply & Forecast
1.2.1 World Diabetes Medicines Production Value (2017 & 2021 & 2028)
1.2.2 World Diabetes Medicines Production (2017-2028)
1.2.3 World Diabetes Medicines Pricing Trends (2017-2028)
1.3 World Diabetes Medicines Production by Region
1.3.1 World Diabetes Medicines Production Value by Region (2017-2028)
1.3.2 World Diabetes Medicines Production by Region (2017-2028)
1.3.3 World Diabetes Medicines Average Price by Region (2017-2028)
1.3.4 North America Diabetes Medicines Production (2017-2028)
1.3.5 Europe Diabetes Medicines Production (2017-2028)
1.3.6 China Diabetes Medicines Production (2017-2028)
1.3.7 Japan Diabetes Medicines Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Diabetes Medicines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Diabetes Medicines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Diabetes Medicines Demand (2017-2028)
2.2 World Diabetes Medicines Consumption by Region
2.2.1 World Diabetes Medicines Consumption by Region (2017-2022)
2.2.2 World Diabetes Medicines Consumption Forecast by Region (2023-2028)
2.3 United States Diabetes Medicines Consumption (2017-2028)
2.4 China Diabetes Medicines Consumption (2017-2028)
2.5 Europe Diabetes Medicines Consumption (2017-2028)
2.6 Japan Diabetes Medicines Consumption (2017-2028)
2.7 South Korea Diabetes Medicines Consumption (2017-2028)
2.8 ASEAN Diabetes Medicines Consumption (2017-2028)
2.9 India Diabetes Medicines Consumption (2017-2028)
3 WORLD DIABETES MEDICINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Diabetes Medicines Production Value by Manufacturer (2017-2022)
3.2 World Diabetes Medicines Production by Manufacturer (2017-2022)
3.3 World Diabetes Medicines Average Price by Manufacturer (2017-2022)
3.4 Diabetes Medicines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Diabetes Medicines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Diabetes Medicines in 2021
3.5.3 Global Concentration Ratios (CR8) for Diabetes Medicines in 2021
3.6 Diabetes Medicines Market: Overall Company Footprint Analysis
3.6.1 Diabetes Medicines Market: Region Footprint
3.6.2 Diabetes Medicines Market: Company Product Type Footprint
3.6.3 Diabetes Medicines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Diabetes Medicines Production Value Comparison
4.1.1 United States VS China: Diabetes Medicines Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Diabetes Medicines Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Diabetes Medicines Production Comparison
4.2.1 United States VS China: Diabetes Medicines Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Diabetes Medicines Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Diabetes Medicines Consumption Comparison
4.3.1 United States VS China: Diabetes Medicines Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Diabetes Medicines Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Diabetes Medicines Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Diabetes Medicines in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Diabetes Medicines Production by Domestic Manufacturer, (2017-2022)
4.5 China Diabetes Medicines Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Diabetes Medicines in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Diabetes Medicines Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Diabetes Medicines Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Diabetes Medicines in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Diabetes Medicines Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Diabetes Medicines Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Insulin
5.2.2 DPP-4
5.2.3 GLP-1
5.2.4 SGLT-2
5.3 Market Segment by Type
5.3.1 World Diabetes Medicines Production by Type (2017-2028)
5.3.2 World Diabetes Medicines Production Value by Type (2017-2028)
5.3.3 World Diabetes Medicines Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Diabetes Medicines Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Type 1 Diabetes
6.2.2 Type 2 Diabetes
6.3 Market Segment by Application
6.3.1 World Diabetes Medicines Production by Application (2017-2028)
6.3.2 World Diabetes Medicines Production Value by Application (2017-2028)
6.3.3 World Diabetes Medicines Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Diabetes Medicines Product and Services
7.1.4 Sanofi Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Diabetes Medicines Product and Services
7.2.4 AstraZeneca Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Diabetes Medicines Product and Services
7.3.4 Bayer Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Biocon
7.4.1 Biocon Details
7.4.2 Biocon Major Business
7.4.3 Biocon Diabetes Medicines Product and Services
7.4.4 Biocon Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Biocon Recent Developments/Updates
7.4.6 Biocon Competitive Strengths & Weaknesses
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Details
7.5.2 Boehringer Ingelheim Major Business
7.5.3 Boehringer Ingelheim Diabetes Medicines Product and Services
7.5.4 Boehringer Ingelheim Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Boehringer Ingelheim Recent Developments/Updates
7.5.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.6 Dongbao Pharmaceutical
7.6.1 Dongbao Pharmaceutical Details
7.6.2 Dongbao Pharmaceutical Major Business
7.6.3 Dongbao Pharmaceutical Diabetes Medicines Product and Services
7.6.4 Dongbao Pharmaceutical Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Dongbao Pharmaceutical Recent Developments/Updates
7.6.6 Dongbao Pharmaceutical Competitive Strengths & Weaknesses
7.7 Eli Lilly
7.7.1 Eli Lilly Details
7.7.2 Eli Lilly Major Business
7.7.3 Eli Lilly Diabetes Medicines Product and Services
7.7.4 Eli Lilly Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Eli Lilly Recent Developments/Updates
7.7.6 Eli Lilly Competitive Strengths & Weaknesses
7.8 Ganlee
7.8.1 Ganlee Details
7.8.2 Ganlee Major Business
7.8.3 Ganlee Diabetes Medicines Product and Services
7.8.4 Ganlee Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Ganlee Recent Developments/Updates
7.8.6 Ganlee Competitive Strengths & Weaknesses
7.9 Ginwa
7.9.1 Ginwa Details
7.9.2 Ginwa Major Business
7.9.3 Ginwa Diabetes Medicines Product and Services
7.9.4 Ginwa Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Ginwa Recent Developments/Updates
7.9.6 Ginwa Competitive Strengths & Weaknesses
7.10 Guangzhou Baiyun Mountain
7.10.1 Guangzhou Baiyun Mountain Details
7.10.2 Guangzhou Baiyun Mountain Major Business
7.10.3 Guangzhou Baiyun Mountain Diabetes Medicines Product and Services
7.10.4 Guangzhou Baiyun Mountain Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Guangzhou Baiyun Mountain Recent Developments/Updates
7.10.6 Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
7.11 Hisun Pharmacy
7.11.1 Hisun Pharmacy Details
7.11.2 Hisun Pharmacy Major Business
7.11.3 Hisun Pharmacy Diabetes Medicines Product and Services
7.11.4 Hisun Pharmacy Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Hisun Pharmacy Recent Developments/Updates
7.11.6 Hisun Pharmacy Competitive Strengths & Weaknesses
7.12 Hua Dong
7.12.1 Hua Dong Details
7.12.2 Hua Dong Major Business
7.12.3 Hua Dong Diabetes Medicines Product and Services
7.12.4 Hua Dong Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Hua Dong Recent Developments/Updates
7.12.6 Hua Dong Competitive Strengths & Weaknesses
7.13 Huadong Medicine
7.13.1 Huadong Medicine Details
7.13.2 Huadong Medicine Major Business
7.13.3 Huadong Medicine Diabetes Medicines Product and Services
7.13.4 Huadong Medicine Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Huadong Medicine Recent Developments/Updates
7.13.6 Huadong Medicine Competitive Strengths & Weaknesses
7.14 Jumpcan Pharmacy
7.14.1 Jumpcan Pharmacy Details
7.14.2 Jumpcan Pharmacy Major Business
7.14.3 Jumpcan Pharmacy Diabetes Medicines Product and Services
7.14.4 Jumpcan Pharmacy Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Jumpcan Pharmacy Recent Developments/Updates
7.14.6 Jumpcan Pharmacy Competitive Strengths & Weaknesses
7.15 KELUN
7.15.1 KELUN Details
7.15.2 KELUN Major Business
7.15.3 KELUN Diabetes Medicines Product and Services
7.15.4 KELUN Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 KELUN Recent Developments/Updates
7.15.6 KELUN Competitive Strengths & Weaknesses
7.16 Merck & Co.
7.16.1 Merck & Co. Details
7.16.2 Merck & Co. Major Business
7.16.3 Merck & Co. Diabetes Medicines Product and Services
7.16.4 Merck & Co. Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Merck & Co. Recent Developments/Updates
7.16.6 Merck & Co. Competitive Strengths & Weaknesses
7.17 MSD
7.17.1 MSD Details
7.17.2 MSD Major Business
7.17.3 MSD Diabetes Medicines Product and Services
7.17.4 MSD Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 MSD Recent Developments/Updates
7.17.6 MSD Competitive Strengths & Weaknesses
7.18 North China Pharmaceutical Group Corporation
7.18.1 North China Pharmaceutical Group Corporation Details
7.18.2 North China Pharmaceutical Group Corporation Major Business
7.18.3 North China Pharmaceutical Group Corporation Diabetes Medicines Product and Services
7.18.4 North China Pharmaceutical Group Corporation Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 North China Pharmaceutical Group Corporation Recent Developments/Updates
7.18.6 North China Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
7.19 Novartis
7.19.1 Novartis Details
7.19.2 Novartis Major Business
7.19.3 Novartis Diabetes Medicines Product and Services
7.19.4 Novartis Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Novartis Recent Developments/Updates
7.19.6 Novartis Competitive Strengths & Weaknesses
7.20 Novo Nordisk
7.20.1 Novo Nordisk Details
7.20.2 Novo Nordisk Major Business
7.20.3 Novo Nordisk Diabetes Medicines Product and Services
7.20.4 Novo Nordisk Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Novo Nordisk Recent Developments/Updates
7.20.6 Novo Nordisk Competitive Strengths & Weaknesses
7.21 Sanofi
7.21.1 Sanofi Details
7.21.2 Sanofi Major Business
7.21.3 Sanofi Diabetes Medicines Product and Services
7.21.4 Sanofi Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 Sanofi Recent Developments/Updates
7.21.6 Sanofi Competitive Strengths & Weaknesses
7.22 SHIJIAZHUANG YILING PHARMACEUTICAL
7.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Details
7.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
7.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Product and Services
7.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.22.5 SHIJIAZHUANG YILING PHARMACEUTICAL Recent Developments/Updates
7.22.6 SHIJIAZHUANG YILING PHARMACEUTICAL Competitive Strengths & Weaknesses
7.23 Takeda
7.23.1 Takeda Details
7.23.2 Takeda Major Business
7.23.3 Takeda Diabetes Medicines Product and Services
7.23.4 Takeda Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.23.5 Takeda Recent Developments/Updates
7.23.6 Takeda Competitive Strengths & Weaknesses
7.24 Taloph
7.24.1 Taloph Details
7.24.2 Taloph Major Business
7.24.3 Taloph Diabetes Medicines Product and Services
7.24.4 Taloph Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.24.5 Taloph Recent Developments/Updates
7.24.6 Taloph Competitive Strengths & Weaknesses
7.25 Tianan Pharmaceutical
7.25.1 Tianan Pharmaceutical Details
7.25.2 Tianan Pharmaceutical Major Business
7.25.3 Tianan Pharmaceutical Diabetes Medicines Product and Services
7.25.4 Tianan Pharmaceutical Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.25.5 Tianan Pharmaceutical Recent Developments/Updates
7.25.6 Tianan Pharmaceutical Competitive Strengths & Weaknesses
7.26 Tonghua DongBao
7.26.1 Tonghua DongBao Details
7.26.2 Tonghua DongBao Major Business
7.26.3 Tonghua DongBao Diabetes Medicines Product and Services
7.26.4 Tonghua DongBao Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.26.5 Tonghua DongBao Recent Developments/Updates
7.26.6 Tonghua DongBao Competitive Strengths & Weaknesses
7.27 Wanbang Biopharmaceuticals
7.27.1 Wanbang Biopharmaceuticals Details
7.27.2 Wanbang Biopharmaceuticals Major Business
7.27.3 Wanbang Biopharmaceuticals Diabetes Medicines Product and Services
7.27.4 Wanbang Biopharmaceuticals Diabetes Medicines Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.27.5 Wanbang Biopharmaceuticals Recent Developments/Updates
7.27.6 Wanbang Biopharmaceuticals Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Diabetes Medicines and Key Manufacturers
8.2 Diabetes Medicines Manufacturing Costs
8.3 Diabetes Medicines Production Process
8.4 Diabetes Medicines Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Diabetes Medicines Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Diabetes Medicines Typical Distributors
9.3 Diabetes Medicines Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Diabetes Medicines Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Diabetes Medicines Production Value by Region (2017-2022) & (USD Million)
Table 3. World Diabetes Medicines Production Value by Region (2023-2028) & (USD Million)
Table 4. World Diabetes Medicines Production Value Market Share by Region (2017-2022)
Table 5. World Diabetes Medicines Production Value Market Share by Region (2023-2028)
Table 6. World Diabetes Medicines Production by Region (2017-2022) & (K Units)
Table 7. World Diabetes Medicines Production by Region (2023-2028) & (K Units)
Table 8. World Diabetes Medicines Production Market Share by Region (2017-2022)
Table 9. World Diabetes Medicines Production Market Share by Region (2023-2028)
Table 10. World Diabetes Medicines Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Diabetes Medicines Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Diabetes Medicines Major Market Trends
Table 13. World Diabetes Medicines Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Diabetes Medicines Consumption by Region (2017-2022) & (K Units)
Table 15. World Diabetes Medicines Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Diabetes Medicines Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Diabetes Medicines Producers in 2021
Table 18. World Diabetes Medicines Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Diabetes Medicines Producers in 2021
Table 20. World Diabetes Medicines Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Diabetes Medicines Company Evaluation Quadrant
Table 22. World Diabetes Medicines Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Diabetes Medicines Production Site of Key Manufacturer
Table 24. Diabetes Medicines Market: Company Product Type Footprint
Table 25. Diabetes Medicines Market: Company Product Application Footprint
Table 26. Diabetes Medicines Competitive Factors
Table 27. Diabetes Medicines New Entrant and Capacity Expansion Plans
Table 28. Diabetes Medicines Mergers & Acquisitions Activity
Table 29. United States VS China Diabetes Medicines Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Diabetes Medicines Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Diabetes Medicines Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Diabetes Medicines in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Diabetes Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Diabetes Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Diabetes Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Diabetes Medicines in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Diabetes Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Diabetes Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Diabetes Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Diabetes Medicines in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Diabetes Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Diabetes Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Diabetes Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Diabetes Medicines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Diabetes Medicines Production by Type (2017-2022) & (K Units)
Table 49. World Diabetes Medicines Production by Type (2023-2028) & (K Units)
Table 50. World Diabetes Medicines Production Value by Type (2017-2022) & (USD Million)
Table 51. World Diabetes Medicines Production Value by Type (2023-2028) & (USD Million)
Table 52. World Diabetes Medicines Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Diabetes Medicines Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Diabetes Medicines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Diabetes Medicines Production by Application (2017-2022) & (K Units)
Table 56. World Diabetes Medicines Production by Application (2023-2028) & (K Units)
Table 57. World Diabetes Medicines Production Value by Application (2017-2022) & (USD Million)
Table 58. World Diabetes Medicines Production Value by Application (2023-2028) & (USD Million)
Table 59. World Diabetes Medicines Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Diabetes Medicines Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Diabetes Medicines Product and Services
Table 64. Sanofi Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Diabetes Medicines Product and Services
Table 70. AstraZeneca Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Diabetes Medicines Product and Services
Table 76. Bayer Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Biocon Basic Information, Manufacturing Base and Competitors
Table 80. Biocon Major Business
Table 81. Biocon Diabetes Medicines Product and Services
Table 82. Biocon Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Biocon Recent Developments/Updates
Table 84. Biocon Competitive Strengths & Weaknesses
Table 85. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 86. Boehringer Ingelheim Major Business
Table 87. Boehringer Ingelheim Diabetes Medicines Product and Services
Table 88. Boehringer Ingelheim Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 91. Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Dongbao Pharmaceutical Major Business
Table 93. Dongbao Pharmaceutical Diabetes Medicines Product and Services
Table 94. Dongbao Pharmaceutical Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Dongbao Pharmaceutical Recent Developments/Updates
Table 96. Dongbao Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 98. Eli Lilly Major Business
Table 99. Eli Lilly Diabetes Medicines Product and Services
Table 100. Eli Lilly Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Eli Lilly Recent Developments/Updates
Table 102. Eli Lilly Competitive Strengths & Weaknesses
Table 103. Ganlee Basic Information, Manufacturing Base and Competitors
Table 104. Ganlee Major Business
Table 105. Ganlee Diabetes Medicines Product and Services
Table 106. Ganlee Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Ganlee Recent Developments/Updates
Table 108. Ganlee Competitive Strengths & Weaknesses
Table 109. Ginwa Basic Information, Manufacturing Base and Competitors
Table 110. Ginwa Major Business
Table 111. Ginwa Diabetes Medicines Product and Services
Table 112. Ginwa Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Ginwa Recent Developments/Updates
Table 114. Ginwa Competitive Strengths & Weaknesses
Table 115. Guangzhou Baiyun Mountain Basic Information, Manufacturing Base and Competitors
Table 116. Guangzhou Baiyun Mountain Major Business
Table 117. Guangzhou Baiyun Mountain Diabetes Medicines Product and Services
Table 118. Guangzhou Baiyun Mountain Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Guangzhou Baiyun Mountain Recent Developments/Updates
Table 120. Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
Table 121. Hisun Pharmacy Basic Information, Manufacturing Base and Competitors
Table 122. Hisun Pharmacy Major Business
Table 123. Hisun Pharmacy Diabetes Medicines Product and Services
Table 124. Hisun Pharmacy Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Hisun Pharmacy Recent Developments/Updates
Table 126. Hisun Pharmacy Competitive Strengths & Weaknesses
Table 127. Hua Dong Basic Information, Manufacturing Base and Competitors
Table 128. Hua Dong Major Business
Table 129. Hua Dong Diabetes Medicines Product and Services
Table 130. Hua Dong Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Hua Dong Recent Developments/Updates
Table 132. Hua Dong Competitive Strengths & Weaknesses
Table 133. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 134. Huadong Medicine Major Business
Table 135. Huadong Medicine Diabetes Medicines Product and Services
Table 136. Huadong Medicine Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Huadong Medicine Recent Developments/Updates
Table 138. Huadong Medicine Competitive Strengths & Weaknesses
Table 139. Jumpcan Pharmacy Basic Information, Manufacturing Base and Competitors
Table 140. Jumpcan Pharmacy Major Business
Table 141. Jumpcan Pharmacy Diabetes Medicines Product and Services
Table 142. Jumpcan Pharmacy Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Jumpcan Pharmacy Recent Developments/Updates
Table 144. Jumpcan Pharmacy Competitive Strengths & Weaknesses
Table 145. KELUN Basic Information, Manufacturing Base and Competitors
Table 146. KELUN Major Business
Table 147. KELUN Diabetes Medicines Product and Services
Table 148. KELUN Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. KELUN Recent Developments/Updates
Table 150. KELUN Competitive Strengths & Weaknesses
Table 151. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 152. Merck & Co. Major Business
Table 153. Merck & Co. Diabetes Medicines Product and Services
Table 154. Merck & Co. Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Merck & Co. Recent Developments/Updates
Table 156. Merck & Co. Competitive Strengths & Weaknesses
Table 157. MSD Basic Information, Manufacturing Base and Competitors
Table 158. MSD Major Business
Table 159. MSD Diabetes Medicines Product and Services
Table 160. MSD Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. MSD Recent Developments/Updates
Table 162. MSD Competitive Strengths & Weaknesses
Table 163. North China Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 164. North China Pharmaceutical Group Corporation Major Business
Table 165. North China Pharmaceutical Group Corporation Diabetes Medicines Product and Services
Table 166. North China Pharmaceutical Group Corporation Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. North China Pharmaceutical Group Corporation Recent Developments/Updates
Table 168. North China Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
Table 169. Novartis Basic Information, Manufacturing Base and Competitors
Table 170. Novartis Major Business
Table 171. Novartis Diabetes Medicines Product and Services
Table 172. Novartis Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Novartis Recent Developments/Updates
Table 174. Novartis Competitive Strengths & Weaknesses
Table 175. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 176. Novo Nordisk Major Business
Table 177. Novo Nordisk Diabetes Medicines Product and Services
Table 178. Novo Nordisk Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Novo Nordisk Recent Developments/Updates
Table 180. Novo Nordisk Competitive Strengths & Weaknesses
Table 181. Sanofi Basic Information, Manufacturing Base and Competitors
Table 182. Sanofi Major Business
Table 183. Sanofi Diabetes Medicines Product and Services
Table 184. Sanofi Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 185. Sanofi Recent Developments/Updates
Table 186. Sanofi Competitive Strengths & Weaknesses
Table 187. SHIJIAZHUANG YILING PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 188. SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
Table 189. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Product and Services
Table 190. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 191. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Developments/Updates
Table 192. SHIJIAZHUANG YILING PHARMACEUTICAL Competitive Strengths & Weaknesses
Table 193. Takeda Basic Information, Manufacturing Base and Competitors
Table 194. Takeda Major Business
Table 195. Takeda Diabetes Medicines Product and Services
Table 196. Takeda Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 197. Takeda Recent Developments/Updates
Table 198. Takeda Competitive Strengths & Weaknesses
Table 199. Taloph Basic Information, Manufacturing Base and Competitors
Table 200. Taloph Major Business
Table 201. Taloph Diabetes Medicines Product and Services
Table 202. Taloph Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 203. Taloph Recent Developments/Updates
Table 204. Taloph Competitive Strengths & Weaknesses
Table 205. Tianan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 206. Tianan Pharmaceutical Major Business
Table 207. Tianan Pharmaceutical Diabetes Medicines Product and Services
Table 208. Tianan Pharmaceutical Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 209. Tianan Pharmaceutical Recent Developments/Updates
Table 210. Tianan Pharmaceutical Competitive Strengths & Weaknesses
Table 211. Tonghua DongBao Basic Information, Manufacturing Base and Competitors
Table 212. Tonghua DongBao Major Business
Table 213. Tonghua DongBao Diabetes Medicines Product and Services
Table 214. Tonghua DongBao Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 215. Tonghua DongBao Recent Developments/Updates
Table 216. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 217. Wanbang Biopharmaceuticals Major Business
Table 218. Wanbang Biopharmaceuticals Diabetes Medicines Product and Services
Table 219. Wanbang Biopharmaceuticals Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 220. Diabetes Medicines Raw Material
Table 221. Key Manufacturers of Diabetes Medicines Raw Materials
Table 222. Diabetes Medicines Typical Distributors
Table 223. Diabetes Medicines Typical Customers
Table 1. World Diabetes Medicines Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Diabetes Medicines Production Value by Region (2017-2022) & (USD Million)
Table 3. World Diabetes Medicines Production Value by Region (2023-2028) & (USD Million)
Table 4. World Diabetes Medicines Production Value Market Share by Region (2017-2022)
Table 5. World Diabetes Medicines Production Value Market Share by Region (2023-2028)
Table 6. World Diabetes Medicines Production by Region (2017-2022) & (K Units)
Table 7. World Diabetes Medicines Production by Region (2023-2028) & (K Units)
Table 8. World Diabetes Medicines Production Market Share by Region (2017-2022)
Table 9. World Diabetes Medicines Production Market Share by Region (2023-2028)
Table 10. World Diabetes Medicines Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Diabetes Medicines Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Diabetes Medicines Major Market Trends
Table 13. World Diabetes Medicines Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Diabetes Medicines Consumption by Region (2017-2022) & (K Units)
Table 15. World Diabetes Medicines Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Diabetes Medicines Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Diabetes Medicines Producers in 2021
Table 18. World Diabetes Medicines Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Diabetes Medicines Producers in 2021
Table 20. World Diabetes Medicines Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Diabetes Medicines Company Evaluation Quadrant
Table 22. World Diabetes Medicines Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Diabetes Medicines Production Site of Key Manufacturer
Table 24. Diabetes Medicines Market: Company Product Type Footprint
Table 25. Diabetes Medicines Market: Company Product Application Footprint
Table 26. Diabetes Medicines Competitive Factors
Table 27. Diabetes Medicines New Entrant and Capacity Expansion Plans
Table 28. Diabetes Medicines Mergers & Acquisitions Activity
Table 29. United States VS China Diabetes Medicines Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Diabetes Medicines Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Diabetes Medicines Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Diabetes Medicines in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Diabetes Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Diabetes Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Diabetes Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Diabetes Medicines in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Diabetes Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Diabetes Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Diabetes Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Diabetes Medicines in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Diabetes Medicines Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Diabetes Medicines Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Diabetes Medicines Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Diabetes Medicines Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Diabetes Medicines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Diabetes Medicines Production by Type (2017-2022) & (K Units)
Table 49. World Diabetes Medicines Production by Type (2023-2028) & (K Units)
Table 50. World Diabetes Medicines Production Value by Type (2017-2022) & (USD Million)
Table 51. World Diabetes Medicines Production Value by Type (2023-2028) & (USD Million)
Table 52. World Diabetes Medicines Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Diabetes Medicines Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Diabetes Medicines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Diabetes Medicines Production by Application (2017-2022) & (K Units)
Table 56. World Diabetes Medicines Production by Application (2023-2028) & (K Units)
Table 57. World Diabetes Medicines Production Value by Application (2017-2022) & (USD Million)
Table 58. World Diabetes Medicines Production Value by Application (2023-2028) & (USD Million)
Table 59. World Diabetes Medicines Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Diabetes Medicines Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Diabetes Medicines Product and Services
Table 64. Sanofi Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Diabetes Medicines Product and Services
Table 70. AstraZeneca Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Diabetes Medicines Product and Services
Table 76. Bayer Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Biocon Basic Information, Manufacturing Base and Competitors
Table 80. Biocon Major Business
Table 81. Biocon Diabetes Medicines Product and Services
Table 82. Biocon Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Biocon Recent Developments/Updates
Table 84. Biocon Competitive Strengths & Weaknesses
Table 85. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 86. Boehringer Ingelheim Major Business
Table 87. Boehringer Ingelheim Diabetes Medicines Product and Services
Table 88. Boehringer Ingelheim Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 91. Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Dongbao Pharmaceutical Major Business
Table 93. Dongbao Pharmaceutical Diabetes Medicines Product and Services
Table 94. Dongbao Pharmaceutical Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Dongbao Pharmaceutical Recent Developments/Updates
Table 96. Dongbao Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 98. Eli Lilly Major Business
Table 99. Eli Lilly Diabetes Medicines Product and Services
Table 100. Eli Lilly Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Eli Lilly Recent Developments/Updates
Table 102. Eli Lilly Competitive Strengths & Weaknesses
Table 103. Ganlee Basic Information, Manufacturing Base and Competitors
Table 104. Ganlee Major Business
Table 105. Ganlee Diabetes Medicines Product and Services
Table 106. Ganlee Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Ganlee Recent Developments/Updates
Table 108. Ganlee Competitive Strengths & Weaknesses
Table 109. Ginwa Basic Information, Manufacturing Base and Competitors
Table 110. Ginwa Major Business
Table 111. Ginwa Diabetes Medicines Product and Services
Table 112. Ginwa Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Ginwa Recent Developments/Updates
Table 114. Ginwa Competitive Strengths & Weaknesses
Table 115. Guangzhou Baiyun Mountain Basic Information, Manufacturing Base and Competitors
Table 116. Guangzhou Baiyun Mountain Major Business
Table 117. Guangzhou Baiyun Mountain Diabetes Medicines Product and Services
Table 118. Guangzhou Baiyun Mountain Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Guangzhou Baiyun Mountain Recent Developments/Updates
Table 120. Guangzhou Baiyun Mountain Competitive Strengths & Weaknesses
Table 121. Hisun Pharmacy Basic Information, Manufacturing Base and Competitors
Table 122. Hisun Pharmacy Major Business
Table 123. Hisun Pharmacy Diabetes Medicines Product and Services
Table 124. Hisun Pharmacy Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Hisun Pharmacy Recent Developments/Updates
Table 126. Hisun Pharmacy Competitive Strengths & Weaknesses
Table 127. Hua Dong Basic Information, Manufacturing Base and Competitors
Table 128. Hua Dong Major Business
Table 129. Hua Dong Diabetes Medicines Product and Services
Table 130. Hua Dong Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Hua Dong Recent Developments/Updates
Table 132. Hua Dong Competitive Strengths & Weaknesses
Table 133. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 134. Huadong Medicine Major Business
Table 135. Huadong Medicine Diabetes Medicines Product and Services
Table 136. Huadong Medicine Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Huadong Medicine Recent Developments/Updates
Table 138. Huadong Medicine Competitive Strengths & Weaknesses
Table 139. Jumpcan Pharmacy Basic Information, Manufacturing Base and Competitors
Table 140. Jumpcan Pharmacy Major Business
Table 141. Jumpcan Pharmacy Diabetes Medicines Product and Services
Table 142. Jumpcan Pharmacy Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Jumpcan Pharmacy Recent Developments/Updates
Table 144. Jumpcan Pharmacy Competitive Strengths & Weaknesses
Table 145. KELUN Basic Information, Manufacturing Base and Competitors
Table 146. KELUN Major Business
Table 147. KELUN Diabetes Medicines Product and Services
Table 148. KELUN Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. KELUN Recent Developments/Updates
Table 150. KELUN Competitive Strengths & Weaknesses
Table 151. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 152. Merck & Co. Major Business
Table 153. Merck & Co. Diabetes Medicines Product and Services
Table 154. Merck & Co. Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Merck & Co. Recent Developments/Updates
Table 156. Merck & Co. Competitive Strengths & Weaknesses
Table 157. MSD Basic Information, Manufacturing Base and Competitors
Table 158. MSD Major Business
Table 159. MSD Diabetes Medicines Product and Services
Table 160. MSD Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. MSD Recent Developments/Updates
Table 162. MSD Competitive Strengths & Weaknesses
Table 163. North China Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 164. North China Pharmaceutical Group Corporation Major Business
Table 165. North China Pharmaceutical Group Corporation Diabetes Medicines Product and Services
Table 166. North China Pharmaceutical Group Corporation Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. North China Pharmaceutical Group Corporation Recent Developments/Updates
Table 168. North China Pharmaceutical Group Corporation Competitive Strengths & Weaknesses
Table 169. Novartis Basic Information, Manufacturing Base and Competitors
Table 170. Novartis Major Business
Table 171. Novartis Diabetes Medicines Product and Services
Table 172. Novartis Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Novartis Recent Developments/Updates
Table 174. Novartis Competitive Strengths & Weaknesses
Table 175. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 176. Novo Nordisk Major Business
Table 177. Novo Nordisk Diabetes Medicines Product and Services
Table 178. Novo Nordisk Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Novo Nordisk Recent Developments/Updates
Table 180. Novo Nordisk Competitive Strengths & Weaknesses
Table 181. Sanofi Basic Information, Manufacturing Base and Competitors
Table 182. Sanofi Major Business
Table 183. Sanofi Diabetes Medicines Product and Services
Table 184. Sanofi Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 185. Sanofi Recent Developments/Updates
Table 186. Sanofi Competitive Strengths & Weaknesses
Table 187. SHIJIAZHUANG YILING PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 188. SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
Table 189. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Product and Services
Table 190. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 191. SHIJIAZHUANG YILING PHARMACEUTICAL Recent Developments/Updates
Table 192. SHIJIAZHUANG YILING PHARMACEUTICAL Competitive Strengths & Weaknesses
Table 193. Takeda Basic Information, Manufacturing Base and Competitors
Table 194. Takeda Major Business
Table 195. Takeda Diabetes Medicines Product and Services
Table 196. Takeda Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 197. Takeda Recent Developments/Updates
Table 198. Takeda Competitive Strengths & Weaknesses
Table 199. Taloph Basic Information, Manufacturing Base and Competitors
Table 200. Taloph Major Business
Table 201. Taloph Diabetes Medicines Product and Services
Table 202. Taloph Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 203. Taloph Recent Developments/Updates
Table 204. Taloph Competitive Strengths & Weaknesses
Table 205. Tianan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 206. Tianan Pharmaceutical Major Business
Table 207. Tianan Pharmaceutical Diabetes Medicines Product and Services
Table 208. Tianan Pharmaceutical Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 209. Tianan Pharmaceutical Recent Developments/Updates
Table 210. Tianan Pharmaceutical Competitive Strengths & Weaknesses
Table 211. Tonghua DongBao Basic Information, Manufacturing Base and Competitors
Table 212. Tonghua DongBao Major Business
Table 213. Tonghua DongBao Diabetes Medicines Product and Services
Table 214. Tonghua DongBao Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 215. Tonghua DongBao Recent Developments/Updates
Table 216. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 217. Wanbang Biopharmaceuticals Major Business
Table 218. Wanbang Biopharmaceuticals Diabetes Medicines Product and Services
Table 219. Wanbang Biopharmaceuticals Diabetes Medicines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 220. Diabetes Medicines Raw Material
Table 221. Key Manufacturers of Diabetes Medicines Raw Materials
Table 222. Diabetes Medicines Typical Distributors
Table 223. Diabetes Medicines Typical Customers
LIST OF FIGURES
Figure 1. Diabetes Medicines Picture
Figure 2. World Diabetes Medicines Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Diabetes Medicines Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Diabetes Medicines Production (2017-2028) & (K Units)
Figure 5. World Diabetes Medicines Average Price (2017-2028) & (US$/Unit)
Figure 6. World Diabetes Medicines Production Value Market Share by Region (2017-2028)
Figure 7. World Diabetes Medicines Production Market Share by Region (2017-2028)
Figure 8. North America Diabetes Medicines Production (2017-2028) & (K Units)
Figure 9. Europe Diabetes Medicines Production (2017-2028) & (K Units)
Figure 10. China Diabetes Medicines Production (2017-2028) & (K Units)
Figure 11. Japan Diabetes Medicines Production (2017-2028) & (K Units)
Figure 12. Diabetes Medicines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Diabetes Medicines Demand (2017-2028) & (K Units)
Figure 15. World Diabetes Medicines Consumption Market Share by Region (2017-2028)
Figure 16. United States Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 17. China Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 18. Europe Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 19. Japan Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 20. South Korea Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 22. India Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Diabetes Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Diabetes Medicines Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Diabetes Medicines Markets in 2021
Figure 26. United States VS China: Diabetes Medicines Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Diabetes Medicines Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Diabetes Medicines Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Diabetes Medicines in United States
Figure 30. Key Producers and Market Share of Diabetes Medicines in China
Figure 31. Key Producers and Market Share of Diabetes Medicines in Rest of World
Figure 32. World Diabetes Medicines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Diabetes Medicines Production Value Market Share by Type in 2021
Figure 34. Insulin
Figure 35. DPP-4
Figure 36. GLP-1
Figure 37. SGLT-2
Figure 38. World Diabetes Medicines Production Market Share by Type (2017-2028)
Figure 39. World Diabetes Medicines Production Value Market Share by Type (2017-2028)
Figure 40. World Diabetes Medicines Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Diabetes Medicines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Diabetes Medicines Production Value Market Share by Application in 2021
Figure 43. Type 1 Diabetes
Figure 44. Type 2 Diabetes
Figure 45. World Diabetes Medicines Production Market Share by Application (2017-2028)
Figure 46. World Diabetes Medicines Production Value Market Share by Application (2017-2028)
Figure 47. World Diabetes Medicines Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Diabetes Medicines in 2021
Figure 49. Manufacturing Process Analysis of Diabetes Medicines
Figure 50. Diabetes Medicines Industrial Chain
Figure 51. Distribution Channel Breakdown for Diabetes Medicines Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Diabetes Medicines Picture
Figure 2. World Diabetes Medicines Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Diabetes Medicines Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Diabetes Medicines Production (2017-2028) & (K Units)
Figure 5. World Diabetes Medicines Average Price (2017-2028) & (US$/Unit)
Figure 6. World Diabetes Medicines Production Value Market Share by Region (2017-2028)
Figure 7. World Diabetes Medicines Production Market Share by Region (2017-2028)
Figure 8. North America Diabetes Medicines Production (2017-2028) & (K Units)
Figure 9. Europe Diabetes Medicines Production (2017-2028) & (K Units)
Figure 10. China Diabetes Medicines Production (2017-2028) & (K Units)
Figure 11. Japan Diabetes Medicines Production (2017-2028) & (K Units)
Figure 12. Diabetes Medicines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Diabetes Medicines Demand (2017-2028) & (K Units)
Figure 15. World Diabetes Medicines Consumption Market Share by Region (2017-2028)
Figure 16. United States Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 17. China Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 18. Europe Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 19. Japan Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 20. South Korea Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 22. India Diabetes Medicines Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Diabetes Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Diabetes Medicines Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Diabetes Medicines Markets in 2021
Figure 26. United States VS China: Diabetes Medicines Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Diabetes Medicines Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Diabetes Medicines Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Diabetes Medicines in United States
Figure 30. Key Producers and Market Share of Diabetes Medicines in China
Figure 31. Key Producers and Market Share of Diabetes Medicines in Rest of World
Figure 32. World Diabetes Medicines Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Diabetes Medicines Production Value Market Share by Type in 2021
Figure 34. Insulin
Figure 35. DPP-4
Figure 36. GLP-1
Figure 37. SGLT-2
Figure 38. World Diabetes Medicines Production Market Share by Type (2017-2028)
Figure 39. World Diabetes Medicines Production Value Market Share by Type (2017-2028)
Figure 40. World Diabetes Medicines Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Diabetes Medicines Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Diabetes Medicines Production Value Market Share by Application in 2021
Figure 43. Type 1 Diabetes
Figure 44. Type 2 Diabetes
Figure 45. World Diabetes Medicines Production Market Share by Application (2017-2028)
Figure 46. World Diabetes Medicines Production Value Market Share by Application (2017-2028)
Figure 47. World Diabetes Medicines Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Diabetes Medicines in 2021
Figure 49. Manufacturing Process Analysis of Diabetes Medicines
Figure 50. Diabetes Medicines Industrial Chain
Figure 51. Distribution Channel Breakdown for Diabetes Medicines Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
